Cancer metabolism: A modeling perspective

Frontiers in Physiology

Volumn 6, Issue DEC, 2015, Pages

  Ghaffari, Pouyan ^a   Mardinoglu, Adil ^a,b   Nielsen, Jens ^a,b,c  

^a CHALMERS UNIVERSITY OF TECHNOLOGY   (Sweden)

^b ROYAL INSTITUTE OF TECHNOLOGY   (Sweden)

^c Chalmers University of Technology   (Denmark)

Author keywords

Cancer metabolism; Genome scale metabolic reconstruction; Metabolic modeling; Metabolic networks and pathways; Systems biology; Systems medicine; Tumor metabolism

Indexed keywords

GLUCOSE; GLUTAMINE; GLYCINE; SERINE;

AMINO ACID SYNTHESIS; ANALYSIS; CANCER CELL; CANCER METABOLISM; CELL SURVIVAL; CONSTRAINT BASED MODELING; FATTY ACID SYNTHESIS; FLUX BALANCE ANALYSIS; GENE INACTIVITY MODERATED BY METABOLISM AND EXPRESSION ALGORITHM; GENETIC ALGORITHM; GENOME SCALE METABOLIC MODEL; GLUCOSE TRANSPORT; GLYCOLYSIS; HUMAN; LIPID METABOLISM; METABOLISM; METASTASIS; MODEL; NEOPLASM; NUCLEAR REPROGRAMMING; NUCLEOTIDE METABOLISM; REVIEW; TUMOR GROWTH; TUMOR MICROENVIRONMENT;

EID: 84953258162     PISSN: None     EISSN: 1664042X     Source Type: Journal    
DOI: 10.3389/fphys.2015.00382     Document Type: Review

References (86)

1. Abramson, H. N. (2011). The lipogenesis pathway as a cancer target. J. Med. Chem. 54, 5615-5638. doi: 10.1021/jm2005805
2. Agren, R., Bordel, S., Mardinoglu, A., Pornputtapong, N., Nookaew, I., and Nielsen, J. (2012). Reconstruction of genome-scale active metabolic networks for 69 human cell types and 16 cancer types using INIT. PLoS Comput. Biol. 8:e1002518. doi: 10.1371/journal.pcbi.1002518
3. Agren, R., Mardinoglu, A., Asplund, A., Kampf, C., Uhlen, M., and Nielsen, J. (2014). Identification of anticancer drugs for hepatocellular carcinoma through personalized genome-scale metabolic modeling. Mol. Syst. Biol. 10, 721. doi: 10.1002/msb.145122
4. Becker, S. A., and Palsson, B. O. (2008). Context-specific metabolic networks are consistent with experiments. PLoS Comput. Biol. 4:e1000082. doi: 10.1371/journal.pcbi.1000082
5. Björnson, E., Mukhopadhyay, B., Asplund, A., Pristovsek, N., Cinar, R., Romeo, S., et al. (2015). Stratification of hepatocellular carcinoma patients based on acetate utilization. Cell Rep. 13, 2014-2026. doi: 10.1016/j.celrep.2015.10.045
6. Boroughs, L. K., and DeBerardinis, R. J. (2015). Metabolic pathways promoting cancer cell survival and growth. Nat. Cell Biol. 17, 351-359. doi: 10.1038/ncb3124
7. Cairns, R. A., Harris, I. S., and Mak, T. W. (2011). Regulation of cancer cell metabolism. Nat. Rev. Cancer 11, 85-95. doi: 10.1038/nrc2981
8. Chabner, B. A., and Roberts, T. G. Jr. (2005). Timeline: chemotherapy and the war on cancer. Nat. Rev. Cancer 5, 65-72. doi: 10.1038/nrc1529
9. Comerford, S. A., Huang, Z., Du, X., Wang, Y., Cai, L., Witkiewicz, A. K., et al. (2014). Acetate dependence of tumors. Cell 159, 1591-1602. doi: 10.1016/j.cell.2014.11.020
10. Covert, M. W., Xiao, N., Chen, T. J., and Karr, J. R. (2008). Integrating metabolic, transcriptional regulatory and signal transduction models in Escherichia coli. Bioinformatics 24, 2044-2050. doi: 10.1093/bioinformatics/btn352
11. Dang, C. V. (2012). Links between metabolism and cancer. Genes Dev. 26, 877-890. doi: 10.1101/gad.189365.112
12. Dang, L., White, D. W., Gross, S., Bennett, B. D., Bittinger, M. A., Driggers, E. M., et al. (2010). Cancer-associated IDH1 mutations produce 2-hydroxyglutarate. Nature 465, 966. doi: 10.1038/nature09132
13. DeBerardinis, R. J., Mancuso, A., Daikhin, E., Nissim, I., Yudkoff, M., Wehrli, S., et al. (2007). Beyond aerobic glycolysis: transformed cells can engage in glutamine metabolism that exceeds the requirement for protein and nucleotide synthesis. Proc. Natl. Acad. Sci. U.S.A. 104, 19345-19350. doi: 10.1073/pnas.0709747104
14. Dolfi, S. C., Chan, L. L., Qiu, J., Tedeschi, P. M., Bertino, J. R., Hirshfield, K. M., et al. (2013). The metabolic demands of cancer cells are coupled to their size and protein synthesis rates. Cancer Metab. 1:20. doi: 10.1186/2049-3002-1-20
15. Duarte, N. C., Becker, S. A., Jamshidi, N., Thiele, I., Mo, M. L., Vo, T. D., et al. (2007). Global reconstruction of the human metabolic network based on genomic and bibliomic data. Proc. Natl. Acad. Sci. U.S.A. 104, 1777-1782. doi: 10.1073/pnas.0610772104
16. Eagle, H., Oyama, V. I., Levy, M., Horton, C. L., and Fleischman, R. (1956). The growth response of mammalian cells in tissue culture to L-glutamine and L-glutamic acid. J. Biol. Chem. 218, 607-616.
17. Feizi, A., Banaei-Esfahani, A., and Nielsen, J. (2015). HCSD: the human cancer secretome database. Database (Oxford) 2015:bav051. doi: 10.1093/database/bav051
18. Feizi, A., and Bordel, S. (2013). Metabolic and protein interaction sub-networks controlling the proliferation rate of cancer cells and their impact on patient survival. Sci. Rep. 3:3041. doi: 10.1038/srep03041
19. Folger, O., Jerby, L., Frezza, C., Gottlieb, E., Ruppin, E., and Shlomi, T. (2011). Predicting selective drug targets in cancer through metabolic networks. Mol. Syst. Biol. 7, 501. doi: 10.1038/msb.2011.35
20. Galluzzi, L., Kepp, O., Vander Heiden, M. G., and Kroemer, G. (2013). Metabolic targets for cancer therapy. Nat. Rev. Drug Discov. 12, 829-846. doi: 10.1038/nrd4145
21. Ghaffari, P., Mardinoglu, A., Asplund, A., Shoaie, S., Kampf, C., Uhlen, M., et al. (2015). Identifying anti-growth factors for human cancer cell lines through genome-scale metabolic modeling. Sci. Rep. 5:8183. doi: 10.1038/srep08183
22. Goldstein, I., Yizhak, K., Madar, S., Goldfinger, N., Ruppin, E., and Rotter, V. (2013). p53 promotes the expression of gluconeogenesis-related genes and enhances hepatic glucose production. Cancer Metab. 1:9. doi: 10.1186/2049-3002-1-9
23. Greaves, M., and Maley, C. C. (2012). Clonal evolution in cancer. Nature 481, 306-313. doi: 10.1038/nature10762
24. Guillaumond, F., Leca, J., Olivares, O., Lavaut, M. N., Vidal, N., Berthezène, P., et al. (2013). Strengthened glycolysis under hypoxia supports tumor symbiosis and hexosamine biosynthesis in pancreatic adenocarcinoma. Proc. Natl. Acad. Sci. U.S.A. 110, 3919-3924. doi: 10.1073/pnas.1219555110
25. Hanahan, D., and Weinberg, R. A. (2000). The hallmarks of cancer. Cell 100, 57-70. doi: 10.1016/S0092-8674(00)81683-9
26. Hanahan, D., and Weinberg, R. A. (2011). Hallmarks of cancer: the next generation. Cell 144, 646-674. doi: 10.1016/j.cell.2011.02.013
27. Hu, J., Locasale, J. W., Bielas, J. H., O'sullivan, J., Sheahan, K., Cantley, L. C., et al. (2013). Heterogeneity of tumor-induced gene expression changes in the human metabolic network. Nat. Biotechnol. 31, 522-529. doi: 10.1038/nbt.2530
28. Hyduke, D. R., Lewis, N. E., and Palsson, B. O. (2013). Analysis of omics data with genome-scale models of metabolism. Mol. Biosyst. 9, 167-174. doi: 10.1039/C2MB25453K
29. Iqbal, M. A., Gupta, V., Gopinath, P., Mazurek, S., and Bamezai, R. N. (2014). Pyruvate kinase M2 and cancer: an updated assessment. FEBS Lett. 588, 2685-2692. doi: 10.1016/j.febslet.2014.04.011
30. Isaacs, J. S., Jung, Y. J., Mole, D. R., Lee, S., Torres-Cabala, C., Chung, Y. L., et al. (2005). HIF overexpression correlates with biallelic loss of fumarate hydratase in renal cancer: novel role of fumarate in regulation of HIF stability. Cancer Cell 8, 143-153. doi: 10.1016/j.ccr.2005.06.017
31. Israelsen, W. J., Dayton, T. L., Davidson, S. M., Fiske, B. P., Hosios, A. M., Bellinger, G., et al. (2013). PKM2 isoform-specific deletion reveals a differential requirement for pyruvate kinase in tumor cells. Cell 155, 397-409. doi: 10.1016/j.cell.2013.09.025
32. Jain, M., Nilsson, R., Sharma, S., Madhusudhan, N., Kitami, T., Souza, A. L., et al. (2012). Metabolite profiling identifies a key role for glycine in rapid cancer cell proliferation. Science 336, 1040-1044. doi: 10.1126/science.1218595
33. Jerby, L., Shlomi, T., and Ruppin, E. (2010). Computational reconstruction of tissue-specific metabolic models: application to human liver metabolism. Mol. Syst. Biol. 6, 401. doi: 10.1038/msb.2010.56
34. Jerby, L., Wolf, L., Denkert, C., Stein, G. Y., Hilvo, M., Oresic, M., et al. (2012). Metabolic associations of reduced proliferation and oxidative stress in advanced breast cancer. Cancer Res. 72, 5712-5720. doi: 10.1158/0008-5472.CAN-12-2215
35. Kamphorst, J. J., Cross, J. R., Fan, J., de Stanchina, E., Mathew, R., White, E. P., et al. (2013). Hypoxic and Ras-transformed cells support growth by scavenging unsaturated fatty acids from lysophospholipids. Proc. Natl. Acad. Sci. U.S.A. 110, 8882-8887. doi: 10.1073/pnas.1307237110
36. Kelloff, G. J., Hoffman, J. M., Johnson, B., Scher, H. I., Siegel, B. A., Cheng, E. Y., et al. (2005). Progress and promise of FDG-PET imaging for cancer patient management and oncologic drug development. Clin. Cancer Res. 11, 2785-2808. doi: 10.1158/1078-0432.CCR-04-2626
37. Labuschagne, C. F., van den Broek, N. J., Mackay, G. M., Vousden, K. H., and Maddocks, O. D. (2014). Serine, but not glycine, supports one-carbon metabolism and proliferation of cancer cells. Cell Rep. 7, 1248-1258. doi: 10.1016/j.celrep.2014.04.045
38. Lee, J. M., Gianchandani, E. P., Eddy, J. A., and Papin, J. A. (2008). Dynamic analysis of integrated signaling, metabolic, and regulatory networks. PLoS Comput. Biol. 4:e1000086. doi: 10.1371/journal.pcbi.1000086
39. Levine, A. J., and Puzio-Kuter, A. M. (2010). The control of the metabolic switch in cancers by oncogenes and tumor suppressor genes. Science 330, 1340-1344. doi: 10.1126/science.1193494
40. Locasale, J. W., Grassian, A. R., Melman, T., Lyssiotis, C. A., Mattaini, K. R., Bass, A. J., et al. (2011). Phosphoglycerate dehydrogenase diverts glycolytic flux and contributes to oncogenesis. Nat. Genet. 43, 869-874. doi: 10.1038/ng.890
41. Lunt, S. Y., Muralidhar, V., Hosios, A. M., Israelsen, W. J., Gui, D. Y., Newhouse, L., et al. (2015). Pyruvate kinase isoform expression alters nucleotide synthesis to impact cell proliferation. Mol. Cell 57, 95-107. doi: 10.1016/j.molcel.2014.10.027
42. Lunt, S. Y., and Vander Heiden, M. G. (2011). Aerobic glycolysis: meeting the metabolic requirements of cell proliferation. Annu. Rev. Cell Dev. Biol. 27, 441-464. doi: 10.1146/annurev-cellbio-092910-154237
43. Maddocks, O. D., Berkers, C. R., Mason, S. M., Zheng, L., Blyth, K., Gottlieb, E., et al. (2012). Serine starvation induces stress and p53-dependent metabolic remodelling in cancer cells. Nature 493, 542-546. doi: 10.1038/nature11743
44. Mardinoglu, A., Agren, R., Kampf, C., Asplund, A., Nookaew, I., Jacobson, P., et al. (2013a). Integration of clinical data with a genome-scale metabolic model of the human adipocyte. Mol. Syst. Biol. 9, 649. doi: 10.1038/msb.2013.5
45. Mardinoglu, A., Agren, R., Kampf, C., Asplund, A., Uhlen, M., and Nielsen, J. (2014). Genome-scale metabolic modelling of hepatocytes reveals serine deficiency in patients with non-alcoholic fatty liver disease. Nat. Commun. 5, 3083. doi: 10.1038/ncomms4083
46. Mardinoglu, A., Gatto, F., and Nielsen, J. (2013b). Genome-scale modeling of human metabolism - a systems biology approach. Biotechnol. J. 8, 985-996. doi: 10.1002/biot.201200275
47. Mardinoglu, A., and Nielsen, J. (2012). Systems medicine and metabolic modelling. J. Intern. Med. 271, 142-154. doi: 10.1111/j.1365-2796.2011.02493.x
48. Mardinoglu, A., and Nielsen, J. (2015). New paradigms for metabolic modeling of human cells. Curr. Opin. Biotech. 34, 91-97. doi: 10.1016/j.copbio.2014.12.013
49. Mardinoglu, A., Shoaie, S., Bergentall, M., Ghaffari, P., Zhang, C., Larsson, E., et al. (2015). The gut microbiota modulates host amino acid and glutathione metabolism in mice Mol. Syst. Biol. 11, 834. doi: 10.15252/msb.20156487
50. Meacham, C. E., and Morrison, S. J. (2013). Tumour heterogeneity and cancer cell plasticity. Nature 501, 328-337. doi: 10.1038/nature12624
51. Meister, A. (1965). Biochemistry of the Amino Acids, 2nd Edn. New York, NY: Academic Press.
52. Menendez, J. A., and Lupu, R. (2007). Fatty acid synthase and the lipogenic phenotype in cancer pathogenesis. Nat. Rev. Cancer 7, 763-777. doi: 10.1038/nrc2222
53. Metallo, C. M., Gameiro, P. A., Bell, E. L., Mattaini, K. R., Yang, J., Hiller, K., et al. (2012). Reductive glutamine metabolism by IDH1 mediates lipogenesis under hypoxia. Nature 481, 380-384. doi: 10.1038/nature10602
54. Mullen, A. R., Wheaton, W. W., Jin, E. S., Chen, P. H., Sullivan, L. B., Cheng, T., et al. (2012). Reductive carboxylation supports growth in tumour cells with defective mitochondria. Nature 481, 385-388. doi: 10.1038/nature10642
55. Niklas, J., Schneider, K., and Heinzle, E. (2010). Metabolic flux analysis in eukaryotes. Curr. Opin. Biotech. 21, 63-69. doi: 10.1016/j.copbio.2010.01.011
56. Oberhardt, M. A., Palsson, B. O., and Papin, J. A. (2009). Applications of genome-scale metabolic reconstructions. Mol. Syst. Biol. 5, 320. doi: 10.1038/msb.2009.77
57. Patel, A. P., Tirosh, I., Trombetta, J. J., Shalek, A. K., Gillespie, S. M., Wakimoto, H., et al. (2014). Single-cell RNA-seq highlights intratumoral heterogeneity in primary glioblastoma. Science 344, 1396-1401. doi: 10.1126/science.1254257
58. Possemato, R., Marks, K. M., Shaul, Y. D., Pacold, M. E., Kim, D., Birsoy, K., et al. (2011). Functional genomics reveal that the serine synthesis pathway is essential in breast cancer. Nature 476, 346-350. doi: 10.1038/nature10350
59. Prabhu, A., Sarcar, B., Kahali, S., Yuan, Z., Johnson, J. J., Adam, K. P., et al. (2014). Cysteine catabolism: a novel metabolic pathway contributing to glioblastoma growth. Cancer Res. 74, 787-796. doi: 10.1158/0008-5472.CAN-13-1423
60. Puchowicz, M. A., Bederman, I. R., Comte, B., Yang, D., David, F., Stone, E., et al. (1999). Zonation of acetate labeling across the liver: implications for studies of lipogenesis by MIDA. Am. J. Physiol. 277, E1022-E1027.
61. Resendis-Antonio, O., González-Torres, C., Jaime-Muñoz, G., Hernandez-Patiño, C. E., and Salgado-Muñoz, C. F. (2015). Modeling metabolism: a window toward a comprehensive interpretation of networks in cancer. Semin. Cancer Biol. 30, 79-87. doi: 10.1016/j.semcancer.2014.04.003
62. Schug, Z. T., Peck, B., Jones, D. T., Zhang, Q., Grosskurth, S., Alam, I. S., et al. (2015). Acetyl-CoA synthetase 2 promotes acetate utilization and maintains cancer cell growth under metabolic stress. Cancer Cell 27, 57-71. doi: 10.1016/j.ccell.2014.12.002
63. Schulze, A., and Harris, A. L. (2012). How cancer metabolism is tuned for proliferation and vulnerable to disruption. Nature 491, 364-373. doi: 10.1038/nature11706
64. Selak, M. A., Armour, S. M., MacKenzie, E. D., Boulahbel, H., Watson, D. G., Mansfield, K. D., et al. (2005). Succinate links TCA cycle dysfunction to oncogenesis by inhibiting HIF-alpha prolyl hydroxylase. Cancer Cell 7, 77-85. doi: 10.1016/j.ccr.2004.11.022
65. Semenza, G. L., Artemov, D., Bedi, A., Bhujwalla, Z., Chiles, K., Feldser, D., et al. (2001). 'The metabolism of tumours': 70 years later. Novartis Found. Symp. 240, 251-260. discussion: 260-254. doi: 10.1002/0470868716.ch17
66. Shlomi, T., Cabili, M. N., Herrgård, M. J., Palsson, B. O., and Ruppin, E. (2008). Network-based prediction of human tissue-specific metabolism. Nat. Biotechnol. 26, 1003-1010. doi: 10.1038/nbt.1487
67. Shoaie, S., Ghaffari, P., Kovatcheva-Datchary, P., Mardinoglu, A., Sen, P., Pujos-Guillot, E., et al. (2015). Quantifying diet-induced metabolic changes of the human gut microbiome. Cell Metab. 22, 320-331. doi: 10.1016/j.cmet.2015.07.001
68. Shukla, S. K., Gebregiworgis, T., Purohit, V., Chaika, N. V., Gunda, V., Radhakrishnan, P., et al. (2014). Metabolic reprogramming induced by ketone bodies diminishes pancreatic cancer cachexia. Cancer Metab. 2:18. doi: 10.1186/2049-3002-2-18
69. Simeonidis, E., and Price, N. D. (2015). Genome-scale modeling for metabolic engineering. J. Ind. Microbiol. Biotechnol. 42, 327-338. doi: 10.1007/s10295-014-1576-3
70. Som, P., Atkins, H. L., Bandoypadhyay, D., Fowler, J. S., MacGregor, R. R., Matsui, K., et al. (1980). A fluorinated glucose analog, 2-fluoro-2-deoxy-D-glucose (F-18): nontoxic tracer for rapid tumor detection. J. Nucl. Med. 21, 670-675. doi: 10.1097/00004728-198012000-00045
71. Sonveaux, P., Végran, F., Schroeder, T., Wergin, M. C., Verrax, J., Rabbani, Z. N., et al. (2008). Targeting lactate-fueled respiration selectively kills hypoxic tumor cells in mice. J. Clin. Invest. 118, 3930-3942. doi: 10.1172/jci36843
72. Stein, W. H., and Moore, S. (1954). The free amino acids of human blood plasma. J. Biol. Chem. 211, 915-926.
73. Thiele, I., and Palsson, B. O. (2010). A protocol for generating a high-quality genome-scale metabolic reconstruction. Nat. Protoc. 5, 93-121. doi: 10.1038/nprot.2009.203
74. Thiele, I., Swainston, N., Fleming, R. M., Hoppe, A., Sahoo, S., Aurich, M. K., et al. (2013). A community-driven global reconstruction of human metabolism. Nat. Biotechnol. 31, 419-425. doi: 10.1038/nbt.2488
75. Tönjes, M., Barbus, S., Park, Y. J., Wang, W., Schlotter, M., Lindroth, A. M., et al. (2013). BCAT1 promotes cell proliferation through amino acid catabolism in gliomas carrying wild-type IDH1. Nat. Med. 19, 901-908. doi: 10.1038/nm.3217
76. Vander Heiden, M. G. (2011). Targeting cancer metabolism: a therapeutic window opens. Nat. Rev. Drug Discov. 10, 671-684. doi: 10.1038/nrd3504
77. Vander Heiden, M. G., Cantley, L. C., and Thompson, C. B. (2009). Understanding the Warburg effect: the metabolic requirements of cell proliferation. Science 324, 1029-1033. doi: 10.1126/science.1160809
78. Wang, Y. L., Eddy, J. A., and Price, N. D. (2012). Reconstruction of genome-scale metabolic models for 126 human tissues using mCADRE. BMC Syst. Biol. 6:153. doi: 10.1186/1752-0509-6-153
79. Warburg, O. (1956). On the origin of cancer cells. Science 123, 309-314. doi: 10.1126/science.123.3191.309
80. Wong, N., Ojo, D., Yan, J., and Tang, D. (2015). PKM2 contributes to cancer metabolism. Cancer Lett. 356, 184-191. doi: 10.1016/j.canlet.2014.01.031
81. Yan, H., Parsons, D. W., Jin, G., McLendon, R., Rasheed, B. A., Yuan, W., et al. (2009). IDH1 and IDH2 mutations in gliomas. N. Engl. J. Med. 360, 765-773. doi: 10.1056/NEJMoa0808710
82. Yizhak, K., Chaneton, B., Gottlieb, E., and Ruppin, E. (2015). Modeling cancer metabolism on a genome scale. Mol. Syst. Biol. 11, 817. doi: 10.15252/msb.20145307
83. Yizhak, K., Le Devedec, S. E., Rogkoti, V. M., Baenke, F., de Boer, V. C., Frezza, C., et al. (2014). A computational study of the Warburg effect identifies metabolic targets inhibiting cancer migration. Mol. Syst. Biol. 10, 744. doi: 10.15252/msb.20145746
84. Yuneva, M. O., Fan, T. W., Allen, T. D., Higashi, R. M., Ferraris, D. V., Tsukamoto, T., et al. (2012). The metabolic profile of tumors depends on both the responsible genetic lesion and tissue type. Cell Metab. 15, 157-170. doi: 10.1016/j.cmet.2011.12.015
85. Zhang, C., Ji, B., Mardinoglu, A., Nielsen, J., and Hua, Q. (2015). Logical transformation of genome-scale metabolic models for gene level applications and analysis. Bioinformatics 31, 2324-2331. doi: 10.1093/bioinformatics/btv134
86. Zhang, J., Fan, J., Venneti, S., Cross, J. R., Takagi, T., Bhinder, B., et al. (2014). Asparagine plays a critical role in regulating cellular adaptation to glutamine depletion. Mol. Cell 56, 205-218. doi: 10.1016/j.molcel.2014.08.018